• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌高危患者血清和肝脏中的类视黄醇及类胡萝卜素状态

Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer.

作者信息

Kataria Yachana, Deaton Ryan J, Enk Erika, Jin Ming, Petrauskaite Milita, Dong Linlin, Goldenberg Joseph R, Cotler Scott J, Jensen Donald M, van Breemen Richard B, Gann Peter H

机构信息

Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA, USA.

Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA.

出版信息

BMC Gastroenterol. 2016 Feb 29;16:30. doi: 10.1186/s12876-016-0432-5.

DOI:10.1186/s12876-016-0432-5
PMID:26927700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4772305/
Abstract

BACKGROUND

Approximately 2.7 million Americans are chronically infected with hepatitis C virus (HCV). HCV patients with cirrhosis form the largest group of persons at high risk for hepatocellular carcinoma (HCC). Increased oxidative stress is regarded as a major mechanism of HCV-related liver disease progression. Deficiencies in retinoid and carotenoid antioxidants may represent a major modifiable risk factor for disease progression. This study aims to identify key predictors of serum antioxidant levels in patients with HCV, to examine the relationship between retinoid/carotenoid concentrations in serum and hepatic tissue, to quantify the association between systemic measures of oxidative stress and antioxidant status, and to examine the relationship between retinoids and stellate cell activation.

METHODS

Patients undergoing liver biopsy (n = 69) provided fasting blood, fresh tissue, urine and completed a diet history questionnaire. Serum and questionnaire data from healthy volunteers (n = 11), normal liver tissue from public repositories and patients without liver disease (n = 11) were also collected. Urinary isoprostanes, serum and tissue retinoid concentrations were obtained by UHPLC-MS-MS. Immunohistochemistry for αSMA was performed on FFPE sections and subsequently quantified via digital image analysis. Associations between urinary isoprostanes, αSMA levels, and retinoids were assessed using Spearman correlation coefficients and non-parametric tests were utilized to test differences among disease severity groups.

RESULTS

There was a significant inverse association between serum retinol, lycopene, and RBP4 concentrations with fibrosis stage. Serum β-carotene and lycopene were strongly associated with their respective tissue concentrations. There was a weak downward trend of tissue retinyl palmitate with increasing fibrosis stage. Tissue retinyl palmitate was inversely and significantly correlated with hepatic αSMA expression, a marker for hepatic stellate cell activation (r = -0.31, P < 0.02). Urinary isoprostanes levels were inversely correlated with serum retinol, β-carotene, and RBP4.

CONCLUSIONS

A decrease in serum retinol, β-carotene, and RBP4 is associated with early stage HCV. Retinoid and carotenoid levels decline as disease progresses, and our data suggest that this decline occurs early in the disease process, even before fibrosis is apparent. Measures of oxidative stress are associated with fibrosis stage and concurrent antioxidant depletion. Vitamin A loss is accompanied by stellate cell activation in hepatic tissue.

摘要

背景

约270万美国人慢性感染丙型肝炎病毒(HCV)。肝硬化的HCV患者是肝细胞癌(HCC)高危人群中最大的群体。氧化应激增加被认为是HCV相关肝病进展的主要机制。类视黄醇和类胡萝卜素抗氧化剂缺乏可能是疾病进展的一个主要可改变风险因素。本研究旨在确定HCV患者血清抗氧化剂水平的关键预测因素,研究血清和肝组织中类视黄醇/类胡萝卜素浓度之间的关系,量化氧化应激的全身指标与抗氧化状态之间的关联,并研究类视黄醇与星状细胞活化之间的关系。

方法

接受肝活检的患者(n = 69)提供空腹血、新鲜组织、尿液并完成饮食史问卷。还收集了健康志愿者(n = 11)的血清和问卷数据、公共储存库中的正常肝组织以及无肝病患者(n = 11)的数据。通过超高效液相色谱-串联质谱法测定尿中异前列腺素、血清和组织类视黄醇浓度。对福尔马林固定石蜡包埋切片进行αSMA免疫组织化学染色,随后通过数字图像分析进行定量。使用Spearman相关系数评估尿中异前列腺素、αSMA水平和类视黄醇之间的关联,并使用非参数检验来检验疾病严重程度组之间的差异。

结果

血清视黄醇、番茄红素和RBP4浓度与纤维化分期呈显著负相关。血清β-胡萝卜素和番茄红素与其各自的组织浓度密切相关。随着纤维化分期增加,组织棕榈酸视黄酯呈微弱的下降趋势。组织棕榈酸视黄酯与肝星状细胞活化标志物肝αSMA表达呈负相关且具有显著性(r = -0.31,P < 0.02)。尿中异前列腺素水平与血清视黄醇、β-胡萝卜素和RBP4呈负相关。

结论

血清视黄醇、β-胡萝卜素和RBP4降低与HCV早期阶段相关。随着疾病进展,类视黄醇和类胡萝卜素水平下降,我们的数据表明这种下降在疾病过程早期就会发生,甚至在纤维化明显之前。氧化应激指标与纤维化分期及同时存在的抗氧化剂消耗相关。肝脏组织中维生素A的丢失伴随着星状细胞活化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7931/4772305/00afa2c233c3/12876_2016_432_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7931/4772305/16c0f7d92a1d/12876_2016_432_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7931/4772305/e03dfede77dd/12876_2016_432_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7931/4772305/7a53760dad80/12876_2016_432_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7931/4772305/67bac35d755d/12876_2016_432_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7931/4772305/77cf2e715a25/12876_2016_432_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7931/4772305/00afa2c233c3/12876_2016_432_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7931/4772305/16c0f7d92a1d/12876_2016_432_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7931/4772305/e03dfede77dd/12876_2016_432_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7931/4772305/7a53760dad80/12876_2016_432_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7931/4772305/67bac35d755d/12876_2016_432_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7931/4772305/77cf2e715a25/12876_2016_432_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7931/4772305/00afa2c233c3/12876_2016_432_Fig6_HTML.jpg

相似文献

1
Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer.肝癌高危患者血清和肝脏中的类视黄醇及类胡萝卜素状态
BMC Gastroenterol. 2016 Feb 29;16:30. doi: 10.1186/s12876-016-0432-5.
2
Differential depletion of carotenoids and tocopherol in liver disease.肝病中类胡萝卜素和生育酚的差异性消耗
Hepatology. 1993 Jun;17(6):977-86.
3
Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C.慢性丙型肝炎患者的血清及肝脏微量营养素抗氧化剂与血清氧化应激
Am J Gastroenterol. 2002 Oct;97(10):2634-9. doi: 10.1111/j.1572-0241.2002.06041.x.
4
High provitamin A carotenoid serum concentrations, elevated retinyl esters, and saturated retinol-binding protein in Zambian preschool children are consistent with the presence of high liver vitamin A stores.赞比亚学龄前儿童血清中高维生素A原类胡萝卜素浓度、升高的视黄酯和饱和视黄醇结合蛋白与肝脏中高维生素A储备的存在相一致。
Am J Clin Nutr. 2015 Aug;102(2):497-504. doi: 10.3945/ajcn.115.112383. Epub 2015 Jul 15.
5
Serum retinoids and beta-carotene as predictors of hip and other fractures in elderly women.血清类视黄醇和β-胡萝卜素作为老年女性髋部及其他骨折的预测指标
J Bone Miner Res. 2005 Jun;20(6):913-20. doi: 10.1359/JBMR.050112. Epub 2005 Jan 24.
6
Micronutrient concentrations in paired skin and plasma of patients with actinic keratoses: effect of prolonged retinol supplementation.光化性角化病患者皮肤与血浆中微量营养素浓度:长期补充视黄醇的影响
Cancer Epidemiol Biomarkers Prev. 1993 Mar-Apr;2(2):145-50.
7
Improved simultaneous determination method of beta-carotene and retinol with saponification in human serum and rat liver.人血清和大鼠肝脏中β-胡萝卜素与视黄醇皂化法同时测定的改进方法
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 5;791(1-2):305-13. doi: 10.1016/s1570-0232(03)00233-2.
8
Prediagnostic level of serum retinol in relation to reduced risk of hepatocellular carcinoma.诊断前血清视黄醇水平与肝细胞癌风险降低的关系。
J Natl Cancer Inst. 2006 Apr 5;98(7):482-90. doi: 10.1093/jnci/djj104.
9
Reduced Carotenoid and Retinoid Concentrations and Altered Lycopene Isomer Ratio in Plasma of Atopic Dermatitis Patients.特应性皮炎患者血浆中类胡萝卜素和视黄醇浓度降低,番茄红素异构体比例改变。
Nutrients. 2018 Oct 1;10(10):1390. doi: 10.3390/nu10101390.
10
Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).非酒精性脂肪性肝病 (NAFLD) 中维生素 A 代谢紊乱。
Nutrients. 2017 Dec 29;10(1):29. doi: 10.3390/nu10010029.

引用本文的文献

1
The role of novel adipokines in hepatocellular carcinoma progression: a mini review.新型脂肪因子在肝细胞癌进展中的作用:一篇综述
Am J Cancer Res. 2024 Nov 15;14(11):5471-5485. doi: 10.62347/PZDM1736. eCollection 2024.
2
Top-Down Proteomics Identifies Plasma Proteoform Signatures of Liver Cirrhosis Progression.自上而下蛋白质组学鉴定肝硬化进展的血浆蛋白质异构体特征
Mol Cell Proteomics. 2024 Dec;23(12):100876. doi: 10.1016/j.mcpro.2024.100876. Epub 2024 Nov 8.
3
Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?

本文引用的文献

1
PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity.PNPLA3 I148M变异影响非酒精性脂肪性肝病或肥胖症成人的循环视黄醇水平。
J Nutr. 2015 Aug;145(8):1687-91. doi: 10.3945/jn.115.210633. Epub 2015 Jul 1.
2
Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study.林县营养干预试验中C反应蛋白、新发肝癌与慢性肝病死亡率之间的关联:一项巢式病例对照研究
Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):386-92. doi: 10.1158/1055-9965.EPI-14-1038. Epub 2015 Jan 22.
3
营养保健品能否支持 MASLD/MASH 的治疗,从而影响肝纤维化的进程?
Int J Mol Sci. 2024 May 11;25(10):5238. doi: 10.3390/ijms25105238.
4
Role of endogenous and exogenous antioxidants in risk of six cancers: evidence from the Mendelian randomization study.内源性和外源性抗氧化剂在六种癌症风险中的作用:孟德尔随机化研究的证据
Front Pharmacol. 2023 Jun 27;14:1185850. doi: 10.3389/fphar.2023.1185850. eCollection 2023.
5
Association of dietary and plasma carotenoids with urinary F-isoprostanes.膳食和血浆类胡萝卜素与尿中 F-异前列烷的关系。
Eur J Nutr. 2022 Aug;61(5):2711-2723. doi: 10.1007/s00394-022-02837-8. Epub 2022 Mar 7.
6
Optimised expression and purification of RBP4 and preparation of anti-RBP4 monoclonal antibody.优化 RBP4 的表达和纯化并制备抗 RBP4 单克隆抗体。
FEBS Open Bio. 2022 Feb;12(2):430-442. doi: 10.1002/2211-5463.13349. Epub 2021 Dec 24.
7
Molecular Crosstalk between the Hepatitis C Virus and the Extracellular Matrix in Liver Fibrogenesis and Early Carcinogenesis.丙型肝炎病毒与细胞外基质在肝纤维化和早期癌变过程中的分子串扰
Cancers (Basel). 2021 May 9;13(9):2270. doi: 10.3390/cancers13092270.
8
Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression.脂肪细胞因子在消化疾病中的作用:炎症、代谢改变和疾病进展的标志物。
Int J Mol Sci. 2020 Nov 5;21(21):8308. doi: 10.3390/ijms21218308.
9
Altering retinol binding protein 4 levels in hepatitis C: Inflammation and steatosis matter.改变丙型肝炎中视黄醇结合蛋白 4 水平:炎症和脂肪变性很重要。
Virulence. 2020 Dec;11(1):1501-1511. doi: 10.1080/21505594.2020.1838742.
10
Role of Mass Spectrometry in Establishing Safety and Efficacy of Botanical Dietary Supplements.质谱分析法在确定植物性膳食补充剂的安全性和有效性方面的作用。
Clin Mass Spectrom. 2020 Jan;15:25-28. doi: 10.1016/j.clinms.2019.12.001. Epub 2020 Jan 7.
Association of serum α-tocopherol, β-carotene, and retinol with liver cancer incidence and chronic liver disease mortality.
血清α-生育酚、β-胡萝卜素和视黄醇与肝癌发病率及慢性肝病死亡率的关联。
Br J Cancer. 2014 Nov 25;111(11):2163-71. doi: 10.1038/bjc.2014.365. Epub 2014 Oct 14.
4
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells.PNPLA3在人肝星状细胞中具有视黄醇棕榈酸酯脂肪酶活性。
Hum Mol Genet. 2014 Aug 1;23(15):4077-85. doi: 10.1093/hmg/ddu121. Epub 2014 Mar 25.
5
Serum antioxidant nutrients, vitamin A, and mortality in U.S. Adults.血清抗氧化营养素、维生素 A 与美国成年人死亡率。
Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2202-11. doi: 10.1158/1055-9965.EPI-13-0381. Epub 2013 Jul 29.
6
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.了解丙型肝炎病毒的生命周期为高效疗法铺平了道路。
Nat Med. 2013 Jul;19(7):837-49. doi: 10.1038/nm.3248.
7
Vital signs: evaluation of hepatitis C virus infection testing and reporting - eight U.S. sites, 2005-2011.生命体征:丙型肝炎病毒感染检测和报告的评估- 2005-2011 年美国八个地点。
MMWR Morb Mortal Wkly Rep. 2013 May 10;62(18):357-61.
8
Method development and validation for ultra-high pressure liquid chromatography/tandem mass spectrometry determination of multiple prostanoids in biological samples.超高压液相色谱/串联质谱法测定生物样品中多种前列腺素的方法开发与验证
J AOAC Int. 2013 Jan-Feb;96(1):67-76. doi: 10.5740/jaoacint.12-280.
9
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.非酒精性脂肪性肝病向糖尿病、心血管疾病或肝硬化的进展。
Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):330-44. doi: 10.1038/nrgastro.2013.41. Epub 2013 Mar 19.
10
PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease.载脂蛋白 L3 I148M 变异与肝细胞癌:一种罕见疾病的常见遗传变异。
Dig Liver Dis. 2013 Aug;45(8):619-24. doi: 10.1016/j.dld.2012.12.006. Epub 2013 Jan 16.